Phase I Dose‐Escalation Study of Pilaralisib (SAR245408, XL147) in Combination with Paclitaxel and Carboplatin in Patients with Solid Tumors

Por Wheler, Jennifer, Mutch, David, Lager, Joanne, Castell, Christelle, Liu, Li, Jiang, Jason, Traynor, Anne M.
Publicado no Oncologist (2017)

Phase I Dose-Escalation Study of Pilaralisib (SAR245408, XL147), a Pan-Class I PI3K Inhibitor, in Combination With Erlotinib in Patients With Solid Tumors

Por Soria, Jean-Charles, LoRusso, Patricia, Bahleda, Ratislav, Lager, Joanne, Liu, Li, Jiang, Jason, Martini, Jean-François, Macé, Sandrine, Burris, Howard
Publicado no Oncologist (2015)

Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan‐Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

Por Edelman, Gerald, Rodon, Jordi, Lager, Joanne, Castell, Christelle, Jiang, Jason, Van Allen, Eliezer M., Wagle, Nikhil, Lindeman, Neal I., Sholl, Lynette M., Shapiro, Geoffrey I.
Publicado no Oncologist (2018)

Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma

Por Wen, Patrick Y., Omuro, Antonio, Ahluwalia, Manmeet S., Fathallah-Shaykh, Hassan M., Mohile, Nimish, Lager, Joanne J., Laird, A. Douglas, Tang, Jiali, Jiang, Jason, Egile, Coumaran, Cloughesy, Timothy F.
Publicado no Neuro Oncol (2015)

Phase I Study of Pazopanib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumors

Por Tan, Antoinette R., Dowlati, Afshin, Jones, Suzanne F., Infante, Jeffrey R., Nishioka, Jennifer, Fang, Lei, Hodge, Jeffrey P., Gainer, Shelby D., Arumugham, Thangam, Suttle, A. Benjamin, Dar, Mohammed M., Lager, Joanne J., Burris, Howard A.
Publicado em 2010

A Phase I Study of Bevacizumab (B) in Combination with Everolimus (E) and Erlotinib (E) in Advanced Cancer (BEE)

Por Bullock, Karen E., Petros, William P., Younis, Islam, Uronis, Hope E., Morse, Michael A., Blobe, Gerard C., Zafar, S. Yousuf, Gockerman, Jon P., Lager, Joanne J., Truax, Roxanne, Meadows, Kellen L., Howard, Leigh A., O’Neill, Margot M., Broadwater, Gloria, Hurwitz, Herbert I., Bendell, Johanna C.
Publicado em 2010

Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial

Por Brown, Jennifer R, Hamadani, Mehdi, Hayslip, John, Janssens, Ann, Wagner-Johnston, Nina, Ottmann, Oliver, Arnason, Jon, Tilly, Hervé, Millenson, Michael, Offner, Fritz, Gabrail, Nashat Y., Ganguly, Siddhartha, Ailawadh, Sikander, Kasar, Siddha, Kater, Arnon P., Doorduijn, Jeanette K., Gao, Lei, Lager, Joanne, Wu, Bin, Egile, Coumaran, Kersten, Marie José
Publicado no Lancet Haematol (2018)